EuBiologics Co., Ltd.

EuBiologics Co., Ltd.verified

206650.KQ

Price:

$12120

Market Cap:

$443.89B

EuBiologics Co., Ltd., a biopharmaceutical company, develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine. The company also provides customized services for mammalian cell and microbial cell derived biopharmaceuticals in accordance with the clients' project stages, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. It specializes in manufacturing a range of mammalian cell and microbial cell derived biopharmaceuticals, including recombinant ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-01-24

Stock Exchange

KOE

Ticker

206650.KQ

The PE Ratio as of December 2025 (TTM) for EuBiologics Co., Ltd. (206650.KQ) is -102.16

According to EuBiologics Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -102.16. This represents a change of -1093.89% compared to the average of 10.28 of the last 4 quarters.

EuBiologics Co., Ltd. (206650.KQ) Historical PE Ratio (quarterly & annually)

How has 206650.KQ PE Ratio performed in the past?

The mean historical PE Ratio of EuBiologics Co., Ltd. over the last ten years is -64.07. The current -102.16 PE Ratio has changed 15.85% with respect to the historical average. Over the past ten years (40 quarters), 206650.KQ's PE Ratio was at its highest in in the March 2022 quarter at 1.89K. The PE Ratio was at its lowest in in the December 2021 quarter at -4514.97.

Quarterly (TTM)
Annual

Average

-64.07

Median

-29.79

Minimum

-286.55

Maximum

39.35

EuBiologics Co., Ltd. (206650.KQ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of EuBiologics Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 535.90%

Maximum Annual PE Ratio = 39.35

Minimum Annual Increase = -720.61%

Minimum Annual PE Ratio = -286.55

Quarterly (TTM)
Annual
YearPE RatioChange
202423.35-180.60%
2023-28.97-89.89%
2022-286.55535.90%
2021-45.06354.06%
2020-9.92-95.94%
2019-244.20-720.61%
201839.35-228.56%
2017-30.61132.96%
2016-13.14-70.76%

EuBiologics Co., Ltd. (206650.KQ) Average PE Ratio

How has 206650.KQ PE Ratio performed in the past?

The current PE Ratio of EuBiologics Co., Ltd. (206650.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-97.39

5-year avg

-69.43

10-year avg

-64.07

EuBiologics Co., Ltd. (206650.KQ) PE Ratio vs. Peers

How is 206650.KQ’s PE Ratio compared to its peers?

EuBiologics Co., Ltd.’s PE Ratio is less than JW Pharmaceutical Corporation (10.80), less than JW Pharmaceutical Corporation (10.80), less than JW Pharmaceutical Corporation (10.80), less than Humedix Co., Ltd. (7.77), less than HLB Pharmaceutical Co., Ltd (103.60), greater than Yungjin Pharm. Co., Ltd. (-3733.94), less than Huons Global Co., Ltd. (25.47), greater than Dong-A ST Co., Ltd. (-989.86), greater than FutureChem Co.,Ltd (-161.51), less than Dentium Co. Ltd. (7.37),

Build a custom stock screener for EuBiologics Co., Ltd. (206650.KQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EuBiologics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

EuBiologics Co., Ltd. (206650.KQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like EuBiologics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is EuBiologics Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for EuBiologics Co., Ltd. (206650.KQ)?

What is the highest PE Ratio for EuBiologics Co., Ltd. (206650.KQ)?

What is the 3-year average PE Ratio for EuBiologics Co., Ltd. (206650.KQ)?

What is the 5-year average PE Ratio for EuBiologics Co., Ltd. (206650.KQ)?

How does the current PE Ratio for EuBiologics Co., Ltd. (206650.KQ) compare to its historical average?